印度反垄断机构批准了 Torrent 对 J 的 11.9B 卢比收购。 B. B. 与 化学品,等待 26%的开放报价。 India's antitrust body clears Torrent's ₹11.9B takeover of J. B. Chemicals, pending a 26% open offer.

印度竞争委员会已批准托伦特制药公司收购J公司。 The Competition Commission of India has approved Torrent Pharmaceuticals' acquisition of J. B. B. 与 B. 化学品和药品,包括来自KKR下属公司的46.39%的股份和来自雇员的2.80%的额外股份,约119亿新西兰克朗,随后公开报价将获得26%以上。 Chemicals & Pharmaceuticals, including a 46.39% stake from KKR’s affiliate and an additional 2.80% from employees, for about ₹11.9 billion, with a subsequent open offer to acquire up to 26% more. 这项交易价值68亿日元,须进行自愿修改,并将导致J。 The deal, valued at ₹6.8 billion, is subject to voluntary modifications and will result in J. B. B. 与 B. 化学品与托伦特合并。 Chemicals merging into Torrent. 这一交易是印度第二大制药交易,目的是扩大托伦特在配方、API和合同制造方面的投资组合。 The transaction, India’s second-largest pharma deal, aims to expand Torrent’s portfolio in formulations, APIs, and contract manufacturing. CCI在修改后没有发现任何重大的竞争问题。 The CCI found no significant competition concerns after the modifications.